Pandemic exposed EU states to worrying pharma supply shortages, leading to widespread calls for more home-manufactured pharma ...
After more than a decade without any therapeutic advancements in chronic obstructive pulmonary disorder (COPD), people with ...
The European Medicines Agency also said that extra doses of the Moderna and Pfizer-BioNTech vaccines could be given to people with underlying health conditions as early as 28 days after a second ...
The European Medicines Agency approved Afqlir and Opuviz to treat age-related macular degeneration while reiterating its ...
Greater collaboration between industry, government, policymakers and the NHS will be critical for treatment options in the UK ...
This marks the regulator's second backing for a use of Wegovy beyond weight loss and further strengthens Novo's case that the ...
An advisory committee has recommended approval in the European Union of marstacimab for severe hemophilia A or B patients without inhibitors.
Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion for an update of Novo Nordisk A/S’ (NYSE ...
The latest health news covers the European Medicines Agency's approval of Novo Nordisk's Wegovy for heart conditions linked ...
U.S. stocks reacted positively following the Federal Open Market Committee's announcement in mid-September that it would lower interest rates by 50 basis points, wider than many analysts had ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback